Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

BACKGROUND: Checkpoint inhibitor pneumonitis (CIP) is an immune-related adverse event that may complicate treatment with immune checkpoint inhibitors (ICI) and can cause significant morbidity. We sought to identify predictors for the development of CIP, and whether the use of inhaled corticosteroids...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Immunol Immunother
Prif Awduron: Li, Mingjia, Spakowicz, Daniel, Zhao, Songzhu, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Miah, Abdul, Husain, Marium, He, Kai, Bertino, Erin M., Shields, Peter G., Wei, Lai, Carbone, David P., Otterson, Gregory A., Presley, Carolyn J., Owen, Dwight H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Berlin Heidelberg 2020
Pynciau:
Research Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572636/
https://ncbi.nlm.nih.gov/pubmed/32728772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02674-w
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg